Abraseed is a venture capital organization focused on supporting pre-seed and seed-stage technology startups in the Middle East and North Africa (MENA) region. The firm aims to drive a shift from natural resource reliance to technology-driven solutions by connecting visionary entrepreneurs with strategic capital from Limited Partners and Business Angels across Europe, the US, North Africa, and Gulf countries.
About Abraseed-1
Abraseed-1 is a UAE-based angel network operating as a special purpose vehicle for MENA-region pre-seed and seed deals. The available record does not list a healthcare thesis, and the network appears sector-agnostic with a regional rather than vertical focus. Founders building healthcare AI tools should be aware that this is not a specialist healthcare backer, and any conversation would likely be opportunistic rather than driven by a clinical investment mandate.
Reported stages are Pre-Seed and Seed. The check size is not publicly disclosed in the source material, and there are no named portfolio companies or team members in the data set. Geographic deployment is most likely concentrated in the Gulf and broader MENA region, although this has not been verified through portfolio disclosures.
For a healthcare AI founder, the practical takeaway is that this is a thin profile with limited public information. There is no signal that Abraseed-1 leads healthcare rounds, runs clinical diligence, or has operating partners with hospital or payer experience. Approaches are more likely to land if the founder already has a regional anchor in the UAE or is fundraising opportunistically alongside a lead investor with a clearer healthcare mandate. Treat this as a possible follow rather than a primary target, and confirm current activity directly through the network’s website before investing meaningful outreach time.
Founder reviews
Team
Pitch / review this investor
Have you raised from Abraseed-1? Founders only — share your honest experience (anonymous OK, moderated before publishing).